Results 141 to 150 of about 38,154 (225)

Age Dependency of the Prognostic Impact of Tumor Genomics in Localized Resectable MYCN-Nonamplified Neuroblastomas. Report From the SIOPEN Biology Group on the LNESG Trials and a COG Validation Group. [PDF]

J Clin Oncol, 2020
Ambros IM, Tonini GP, Pötschger U, Gross N, Mosseri V, Beiske K, Berbegall AP, Bénard J, Bown N, Caron H, Combaret V, Couturier J, Defferrari R, Delattre O, Jeison M, Kogner P, Lunec J, Marques B, Martinsson T, Mazzocco K, Noguera R, Schleiermacher G, Valent A, Van Roy N, Villamon E, Janousek D, Pribill I, Glogova E, Attiyeh EF, Hogarty MD, Monclair TF, Holmes K, Valteau-Couanet D, Castel V, Tweddle DA, Park JR, Cohn S, Ladenstein R, Beck-Popovic M, De Bernardi B, Michon J, Pearson ADJ, Ambros PF.   +42 more
europepmc   +1 more source

Lorlatinib with or without chemotherapy in ALK-driven refractory/relapsed neuroblastoma: phase 1 trial results. [PDF]

Nat Med, 2023
Goldsmith KC, Park JR, Kayser K, Malvar J, Chi YY, Groshen SG, Villablanca JG, Krytska K, Lai LM, Acharya PT, Goodarzian F, Pawel B, Shimada H, Ghazarian S, States L, Marshall L, Chesler L, Granger M, Desai AV, Mody R, Morgenstern DA, Shusterman S, Macy ME, Pinto N, Schleiermacher G, Vo K, Thurm HC, Chen J, Liyanage M, Peltz G, Matthay KK, Berko ER, Maris JM, Marachelian A, Mossé YP.   +34 more
europepmc   +1 more source

Segmental chromosome aberrations as a prognostic factor of neuroblastoma: a meta-analysis and systematic review. [PDF]

Transl Pediatr
Geng J, Wang X, Zhao L, Zhang J, Niu H.
europepmc   +1 more source

Bevacizumab, Irinotecan, or Topotecan Added to Temozolomide for Children With Relapsed and Refractory Neuroblastoma: Results of the ITCC-SIOPEN BEACON-Neuroblastoma Trial. [PDF]

J Clin Oncol
Moreno L, Weston R, Owens C, Valteau-Couanet D, Gambart M, Castel V, Zwaan CM, Nysom K, Gerber N, Castellano A, Laureys G, Ladenstein R, Rössler J, Makin G, Murphy D, Morland B, Vaidya S, Thebaud E, van Eijkelenburg N, Tweddle DA, Barone G, Tandonnet J, Corradini N, Chastagner P, Paillard C, Bautista FJ, Gallego Melcon S, De Wilde B, Marshall L, Gray J, Burchill SA, Schleiermacher G, Chesler L, Peet A, Leach MO, McHugh K, Hayes R, Jerome N, Caron H, Laidler J, Fenwick N, Holt G, Moroz V, Kearns P, Gates S, Pearson ADJ, Wheatley K, Innovative Therapies for Children with Cancer (ITCC) and European Association for Neuroblastoma Research (SIOPEN).   +47 more
europepmc   +1 more source

Choosing the best apple: counselling leaflets and technologies of communication in the history of reproduction. [PDF]

Med Humanit, 2023
Nemec B.
europepmc   +1 more source

Neurological hospitalisations in childhood cancer survivors treated before 2001: findings from the French Childhood Cancer Survivor Study cohort. [PDF]

BMC Neurol
Rajaonera D, Bejarano-Quisoboni D, Grill J, Allodji RS, Pelletier-Fleury N, Journy N, Boussac M, Doz F, Vu-Bezin G, Zidane M, Schwartz B, Haddy N, Bolle S, El-Fayech C, Dufour C, Diallo I, Schleiermacher G, Fresneau B, de Vathaire F.   +18 more
europepmc   +1 more source

Interpretasi milenial Muhammad Shahrur tentang isu-isu perempuan. [PDF]

F1000Res, 2023
Herlambang S.
europepmc   +1 more source

15 Years Old ALK Gene from Birth to Adolescence; Where to in NBL. [PDF]

Curr Oncol Rep
Elmenawi S, Fawzy M.
europepmc   +1 more source

17q Gain in Neuroblastoma: A Review of Clinical and Biological Implications. [PDF]

Cancers (Basel)
Mlakar V, Dupanloup I, Gonzales F, Papangelopoulou D, Ansari M, Gumy-Pause F.   +5 more
europepmc   +1 more source

Imaging characterization of paediatric tumours with the neurotrophic tyrosine receptor kinase fusion transcript. [PDF]

Br J Radiol
Hermann AL, Lemelle L, Pierron G, Gauthier A, Nicolas N, Cardoen L, Moalla S, Petit P, Morel B, Ducou Le Pointe H, Hassani A, Fréneaux P, Guillemot D, Carton M, Corradini N, Rome A, Castex MP, Defachelles AS, Schleiermacher G, Berlanga P, Delattre O, Orbach D, Brisse HJ.   +22 more
europepmc   +1 more source